Albert Bourla, Pfizer CEO (Michael Nagle/Bloomberg via Getty Images)
Pfizer sticks to the script in first-quarter update as cost cuts are 'largely complete'
The Covid-era swagger is gone. The cost cuts are mostly done. The executives are “cautiously optimistic.” And the stock is up.
On Wednesday, Pfizer stayed …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
